Mental Health Issues Triple Among UK Students

Updated Feb 20, 2025 | 08:55 AM IST

SummaryAs per the latest data, the number of mental health cases tripled among students in the UK. The worse affected are LGBTQ students and women.
Mental Health Issues Triple Among UK Students

Credits: Canva

As per the latest data released by Transforming Access to Student Outcomes in Higher Education (TASO) and the Policy Institute at King's College London, the number of UK students reporting mental health difficulties tripled. The estimate reveals that around 300,000 students could now be experiencing mental health struggles. Of the total, 18% of students reported some kind of mental health issue in 2024.

As per the reports, this estimate is triple what was reported in 2017, where it was at 6%. Experts also say that Covid-19 pandemic is "often considered to have contributed to this, it does not explain the ongoing rise in mental health difficulties." Another reason could also be the "changing definition and increasing openness about mental health" which has led to a rise in numbers. The report notes, "This trend pre-dates the Covid-19 pandemic and the cost-of-living crisis. Although these factors play a part in students' deteriorating mental health, they cannot therefore be the only explanation."

How Did The Report Conclude?

The report drew data collected over the latest Student Academic Experience Survey of 93,212 students. From the survey, it was found that there exist significant disparities between demographic groups, with women being twice as likely to report mental health difficulties, about 22% as compared to men, at 11%.

What Did The Results Reveal?

The results revealed that students who identified as LGBTQ experienced the highest rates of mental health challenges. This has actually lessened the hope that conditions for LGBTQ students are improving, which may not have been a positive case.

Of them, 42% are bisexual and lesbian students, whereas last year it was 35% and 32% respectively. The report also noted that mental health difficulties among lesbian women and gay men rose three times the rate of straight people, and among bisexual and asexual people, it was twice as high. For trans students, the number jumped from 25% in 2023 to 40% in 2024.

Is The LGBTQ+ Prone To Mental Health Crisis?

As per the Child Mind Institute, being LGBTQ+ does not cause mental health problems, but because these kids often face factors like rejection, discrimination and violence, they are at a higher risk of challenges including depression, anxiety, and even attempting suicide.

A UTAH Health study quotes Anna Docherty, PhD, LP, assistant professor of psychiatry at Huntsman Mental Health Institute that, "likely with any identity, feeling different - or worse, unaccepted as you are is a significant risk factor of mental health struggle." The data reveals that LGBTQ+ teens are six times more likely to experience symptoms of depression than non-LGBTQ+ identifying teens. They are also more than twice as likely to feel suicidal and more than four times as likely to attempt suicide. In the US alone, 48% of transgender adults report that they have considered suicide in the last year, compared to 4% of the overall population.

What Do These Findings Mean?

TASO's academic lead and professor of public policy at King's College London, Michael Sanders said, "LGBTQ students and women bear the brunt of the rise in declining mental health and urgent action is needed to understand and address these trends."

End of Article

Not Just US, Mexico & Bolivia Also Lose Measles-Free Status: RFK Jr & CDC Chief Respond

Updated Nov 18, 2026 | 08:53 AM IST

SummaryThe Pan American Health Organization (PAHO) recently announced that the United States, Mexico and Bolivia have lost their measles-free status as they failed to interrupt transmission over a period of 12 months.
Not Just US, Mexico & Bolivia Also Lose Measles-Free Status: RFK Jr & CDC Chief Respond

Credit: AI image

The United States is not the only country to lose its measles elimination status this year. Mexico and Bolivia have also lost the status after the highly contagious virus continued spreading for more than 12 months, according to the Pan American Health Organization (PAHO).

The decision was formally announced on November 17, 2026 by PAHO's independent Regional Monitoring and Re-Verification Commission, which reviewed measles data from 47 countries and territories across the Americas.

The United States had maintained its measles elimination status since 2000, while Mexico and Bolivia had also previously interrupted sustained local transmission. The latest development marks a setback in efforts to control a disease that can be prevented through vaccination.

The announcement comes as measles cases continue to rise across the region. As of November 13, 2026, the Americas had reported 58,213 confirmed cases and 82 deaths, compared with 12,806 cases during the same period in 2025.

Three Countries In Americas Lose Measles-Free Status

Also read: 112 Pregnant Women, 13 Newborns Infected With Measles In US Since 2025: CDC

According to PAHO, a country loses its measles elimination status when the same measles virus genotype and lineage circulates continuously within its borders for at least 12 months. This indicates that the virus has re-established endemic transmission rather than appearing only through isolated cases imported from other countries.

According to PAHO, the sustained transmission periods in the three countries began on different dates:

  • United States: The outbreak began on January 20, 2025, reaching the 12-month threshold on January 20, 2026.
  • Mexico: The outbreak began on February 1, 2025, reaching the one-year mark on February 1, 2026.
  • Bolivia: The outbreak began on April 16, 2025, marking one year of continued transmission on April 16, 2026.

Losing elimination status does not mean that measles is spreading everywhere within these countries. It means that the same virus lineage has continued circulating locally for at least a year.

The Americas had previously lost its regional measles elimination status in November 2025, after Canada reported to have sustained transmission for more than 12 months. The region had first eliminated measles in 2016 and regained that achievement in 2024 after stopping transmission in Venezuela and Brazil.

What Did HHS Secretary Robert F Kennedy Jr And CDC Chief Dr Erica Schwartz Say?

Also read: US Loses Measles Elimination Status After 26 Years: What Does It Mean?

After PAHO's announcement, US Health and Human Services Secretary Robert F. Kennedy Jr and Centers for Disease Control and Prevention (CDC) Director Dr Erica Schwartz issued separate statements.

Kennedy said the administration would continue working to control outbreaks and restore the country's elimination status.

"We will stop measles outbreaks, protect American families, and work to regain U.S. measles elimination status," he said in a statement. He also expressed his support for vaccination, adding, "I continue to recommend MMR vaccination as the most effective way to prevent measles."

Kennedy attributed gaps in childhood immunisation to disruptions during the COVID-19 pandemic which affected routine vaccination programmes in the US and other countries.

He also said that approximately $100 million in additional CDC funding has been provided since August to strengthen measles prevention and outbreak response. The funding is intended to support state and local health departments, improve surveillance and help close vaccination gaps.

CDC Director Dr Schwartz said the loss of the designation would not change the agency's approach to controlling the disease.

"The measles elimination designation is not what protects Americans. Vaccination does. We know where transmission is occurring and we've invested $100 million in state and local health departments to reach those communities," she said.

"Losing a designation doesn't mean we abandon an evidence-based approach. It means we remain focused on stopping outbreaks."

Also read: RFK Jr's Vaccine Controversy: What His Samoa Trip Has To Do With 83 Measles Deaths

Measles Resurgence In The Americas

The latest PAHO figures highlight the scale of the resurgence. The region recorded more than four times as many confirmed measles cases by November 13, 2026 as during the corresponding period in 2025.

Mexico has reported more than 13,900 confirmed cases so far in 2026, the highest annual total since the 1989-90 epidemic. The US has recorded more than 5,400 cases and 10 deaths, its highest in more than 35 years. Bolivia has reported more than 100 cases.

Amid the resurgence, a CDC report has identified 112 measles infections among pregnant women in the US between January 2025 and September 2026, along with 13 cases of congenital measles in newborns. Nearly all the women were unvaccinated or had an unknown vaccination status.

Measles is among the most contagious infectious diseases. One infected person can transmit the virus to as many as 18 people who are susceptible to infection.

The disease typically causes fever, cough, a runny nose, red and watery eyes, followed by a characteristic skin rash. However, it can also lead to serious complications, including pneumonia, brain inflammation (encephalitis), blindness and death. It can also weaken the immune system for months after infection.

Can The Countries Regain Measles Elimination Status?

PAHO expects the US, Mexico and Bolivia to submit plans outlining how they plan to interrupt transmission and strengthen measles vaccination and surveillance.

The organisation has called on countries across the Americas to achieve and maintain at least 95% coverage with both doses of the measles vaccine.

The MMR vaccine, which protects against measles, mumps and rubella, remains the most effective way to prevent measles.

End of Article

US FDA Approves First Drug To Cut Death Risk By 55% In Niemann-Pick Patients: What Is The Rare Disease?

Updated Nov 18, 2026 | 07:02 AM IST

SummaryNiemann-Pick disease type C (NPC) is a rare inherited disorder that affects the body's ability to process cholesterol. Lembaz addresses this underlying cause, extending life expectancy.
US FDA Approves First Drug To Cut Death Risk By 55% In Niemann-Pick Patients: What Is The Rare Disease?

Credit: AI image

The US Food and Drug Administration (FDA) has granted approval to a new drug that could help patients with a rare and life-threatening genetic disorder live longer. The treatment, Lembaz (adrabetadex), is the first drug proven to reduce the risk of death in patients with infantile-onset Niemann-Pick disease type C (NPC).

Announced on November 17, 2026, the approval marks an important development for families affected by the rare disease, which causes progressive neurological damage and can significantly shorten life expectancy.

Lembaz is approved for adults and children weighing at least 7 kg (approximately 15 pounds) whose neurological symptoms began before the age of six. It is administered as an injection directly into the fluid surrounding the spinal cord, a procedure known as an intrathecal injection, every two weeks.

"For the first time, there is a treatment shown to help adults and children with this serious disease live longer," said Acting FDA Commissioner Kyle Diamantas.

Lembaz Reduces Risk Of Death By 55% In Niemann-Pick Patients

Also read: Trials For Deadly Childhood Brain Cancer Stalled After Trump Administration Shuts Down 27-Year Research Consortium

The FDA's approval was based on data from 36 patients treated with Lembaz across three clinical studies. Their outcomes were compared to an external control group of patients who had not received the treatment.

The analysis found that patients who received Lembaz had a 55% lower risk of death compared to the control group.

The median overall survival was 8.5 years among patients treated with Lembaz compared to 4.9 years in the control group.

The benefit was observed regardless of whether patients were also receiving miglustat, another medicine used to manage NPC.

What Is Niemann-Pick Disease Type C?

Also read: Childhood Obesity: Wegovy Cuts BMI By 10% In Children As Young As 6; What Are The Risks?

Niemann-Pick disease type C is a rare inherited disorder that affects the body's ability to process cholesterol and other fatty substances inside cells.

The condition is caused by changes in either the NPC1 or NPC2 gene. These genes produce proteins that help move cholesterol and other lipids within cells. When these proteins do not function properly, fatty substances accumulate inside cells, affecting organs like liver, spleen and brain. Over time, this causes progressive damage to the nervous system.

Patients may experience difficulties with movement, balance, coordination, speech and swallowing. Some may also face seizures, cognitive difficulties and problems controlling eye movements.

The disease affects approximately one in 150,000 people, according to the FDA. Its symptoms and severity can vary depending on when the disease begins.

Infantile-Onset Niemann-Pick Disease Can Be Severe

Also read: 112 Pregnant Women, 13 Newborns Infected With Measles In US Since 2025: CDC

Infantile-onset NPC refers to cases in which neurological symptoms start before the age of six. These patients experience a more aggressive disease as they face rapid progressive neurological deterioration and a shorter life expectancy.

As the disease advances, children may gradually lose the ability to walk, speak and swallow independently. Difficulties with swallowing can also increase the risk of respiratory complications.

There is currently no cure for NPC, making treatments that can slow disease progression or improve survival important.

More About Lembaz

Lembaz contains adrabetadex, a cyclodextrin-based medicine made to address the underlying cholesterol processing defect in NPC.

In simple terms, the drug helps move cholesterol trapped inside cells, especially brain cells, so that it can be transported to areas where it is needed.

By targeting this underlying problem, the treatment aims to reduce the cellular damage that comes with the disease.

According to the FDA, hearing impairment, including permanent hearing loss, could be one of the side effects of Lembaz. Hence, patients must undergo hearing assessments before starting the drug and regularly throughout the course.

Other common side effects include balance and coordination problems, fatigue, vomiting, back pain, headache, fever, diarrhoea, nausea and cough.

End of Article

112 Pregnant Women, 13 Newborns Infected With Measles In US Since 2025: CDC

Updated Nov 18, 2026 | 02:00 AM IST

SummarySummary: A CDC-led report identified 112 measles infections among pregnant women and 13 cases of congenital measles in newborns in the US between January 2025 and September 2026. Nearly all infected women were unvaccinated or had an unknown vaccination status, highlighting the risks of declining immunization amid ongoing outbreaks.
112 Pregnant Women, 13 Newborns Infected With Measles In US Since 2025: CDC

Credit: AI Image

The US has lost its measles elimination status after 26 years, with Bolivia and Mexico also losing the designation, the Pan American Health Organization (PAHO) announced on Tuesday. The decision follows more than 12 months of continuous measles transmission in the US.

Amid the resurgence, a CDC-led report has identified 112 measles infections among pregnant women in the US between January 2025 and September 2026, along with 13 cases of congenital measles in newborns. Nearly all the women were unvaccinated or had an unknown vaccination status.

The actual number of infections among pregnant women may be higher. A separate CIDRAP News investigation based on state health department data identified at least 167 pregnant women infected in 2025 and 2026.

Measles In Unvaccinated Women

Also Read: What Happens After Measles Infection? The Hidden Risks That Can Last For Years

The CDC-led report, published in NEJM Evidence journal, found that 108 (96%) of the 112 cases occurred during outbreaks involving 50 or more cases.

Of the infected women, 110 (98%) had received no MMR vaccine doses or had an unknown vaccination status.

Twenty-six women (23%) were hospitalized for reasons unrelated to childbirth, while 11 (10%) developed pneumonia.

“Even though measles is an old disease, measles in pregnancy is an emerging area that we need to learn about,” said Michelle Barton, a professor at the Schulich School of Medicine & Dentistry at Western University.

Measles In Newborns

Read More: Congenital Measles Reported In Pennsylvania For First Time In Decades: What Parents Should Know

The report recorded 21 pregnancy outcomes within 14 days of maternal rash onset: 19 live births and two pregnancy losses, including one miscarriage and one stillbirth.

Eight babies were born prematurely, and eight required admission to a neonatal intensive care unit (NICU).

The report noted that 13 babies had congenital measles and tested positive for the virus. Of these, six developed symptoms, including one with signs compatible with meningoencephalitis, a potentially life-threatening inflammation of the brain and surrounding membranes.

The authors said the outbreaks highlighted measles' risks to maternal and newborn health.

Many doctors and nurses treating these patients have never encountered measles, relying largely on medical training and professional guidelines to manage the infections.

The CDC recommends intravenous immunoglobulin as post-exposure prophylaxis for pregnant women without documented MMR vaccination or other evidence of immunity who are exposed to measles.

Newborns exposed to measles in the womb should also receive immunoglobulin at birth. Congenital measles can cause severe neurological complications, including subacute sclerosing panencephalitis (SSPE), a rare, progressive brain disorder.

US Loses Measles Elimination Status After 26 Years

The US is experiencing its highest measles burden in more than three decades. Since 2025, approximately 7,700 people have been infected and 13 have died, according to the figures cited in the report.

As of November 12, the CDC had confirmed 5,412 cases and six deaths in 2026. States had reported 10 deaths.

The rise in infections has coincided with declining vaccination rates and growing vaccine hesitancy. US Health Secretary Robert F. Kennedy Jr. has repeatedly questioned measles vaccine safety without scientific evidence supporting those claims.

The CDC said it would work to stop outbreaks and regain elimination status by supporting states and providing sustained national leadership.

"The measles elimination designation is not what protects Americans; vaccination does," CDC Director Erica Schwartz said.

End of Article